Daily methylphenidate and atomoxetine treatment impacts on clock gene protein expression in the mouse brain.

Daily methylphenidate and atomoxetine treatment impacts on clock gene protein expression in the mouse brain.

Circadian rhythms are repeating patterns of physiological and other parameters that recur with periods of approximately 24h, and are generated by an endogenous circadian timekeeping mechanism. Such circadian rhythms, and their underlying molecular mechanisms, are known to be altered by a number of c...

Detaylı Bibliyografya
Asıl Yazarlar:	Baird, A, Coogan, A, Kaufling, J, Barrot, M, Thome, J
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2013

Benzer Materyaller

Haloperidol alters circadian clock gene product expression in the mouse brain.
Yazar:: Coogan, A, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Atomoxetine and Methylphenidate Treatment in ADHD
Yazar:: Snircova E., ve diğerleri
Baskı/Yayın Bilgisi: (2015-05-01)

Effects of Methylphenidate and Atomoxetine on Cortical Inhibition in ADHD
Yazar:: J Gordon Millichap
Baskı/Yayın Bilgisi: (2006-09-01)

Atomoxetine/Methylphenidate Effects on Social Play Behavior
Yazar:: J Gordon Millichap
Baskı/Yayın Bilgisi: (2015-02-01)

Different effects of methylphenidate and atomoxetine on the behavior and brain transcriptome of zebrafish
Yazar:: Shiho Suzuki, ve diğerleri
Baskı/Yayın Bilgisi: (2020-05-01)

Psychosis with use of amphetamine drugs, methylphenidate and atomoxetine in adolescent and adults
Yazar:: François Montastruc, ve diğerleri
Baskı/Yayın Bilgisi: (2024-05-01)

Adverse pregnancy outcomes after exposure to methylphenidate or atomoxetine during pregnancy
Yazar:: Bro SP, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

Functional outcomes of extended-release methylphenidate and atomoxetine in children: retrospective chart analysis
Yazar:: Armagan Aral, ve diğerleri
Baskı/Yayın Bilgisi: (2022-08-01)

Extended Efficacy of Once-Daily Atomoxetine in ADHD
Yazar:: J Gordon Millichap
Baskı/Yayın Bilgisi: (2004-07-01)

Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine
Yazar:: Joseph A, ve diğerleri
Baskı/Yayın Bilgisi: (2016-03-01)

Mental Health or Cardiac Health. Is there a reason to choose? Cardiac arrhythmias induced by Atomoxetine and Methylphenidate
Yazar:: Gabriel Cismaru, ve diğerleri
Baskı/Yayın Bilgisi: (2021-10-01)

Methylphenidate and atomoxetine prescribing trends in children in the Western Cape Province of South Africa, 2005–2013
Yazar:: Liezl Joubert, ve diğerleri
Baskı/Yayın Bilgisi: (2018-07-01)

A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorder
Yazar:: Ball Susan, ve diğerleri
Baskı/Yayın Bilgisi: (2007-09-01)

Risk of Suicidal Events in Youths Taking Atomoxetine Compared with Those on Methylphenidate; An Observational Cross-Sectional Study
Yazar:: Padideh Ghaeli, ve diğerleri
Baskı/Yayın Bilgisi: (2021-12-01)

Characterization of Amphetamine, Methylphenidate, Nicotine, and Atomoxetine on Measures of Attention, Impulsive Action, and Motivation in the Rat: Implications for Translational Research
Yazar:: Guy A. Higgins, ve diğerleri
Baskı/Yayın Bilgisi: (2020-04-01)

A modelled economic evaluation comparing atomoxetine with methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder in Spain
Yazar:: Dilla Tatiana, ve diğerleri
Baskı/Yayın Bilgisi: (2009-04-01)

CLOCK Genes and Circadian Rhythmicity in Alzheimer Disease
Yazar:: J. Thome, ve diğerleri
Baskı/Yayın Bilgisi: (2011-01-01)

Efficacy and Safety of Methylphenidate and Atomoxetine in Medication-Naive Children with Attention-Deficit Hyperactivity Disorder in a Real-World Setting
Yazar:: Ying Zhang, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01)

Safety profiles of methylphenidate, amphetamine, and atomoxetine: analysis of spontaneous reports submitted to the food and drug administration adverse event reporting system
Yazar:: Wei Wei, ve diğerleri
Baskı/Yayın Bilgisi: (2023-08-01)

Atomoxetine might be more effective in improving sluggish cognitive tempo symptoms after switching from methylphenidate: A case report
Yazar:: Akın Tahıllıoğlu, ve diğerleri
Baskı/Yayın Bilgisi: (2021-02-01)

Chronic Methylphenidate Effects on Brain Gene Expression: An Exploratory Review
Yazar:: Klein SR, ve diğerleri
Baskı/Yayın Bilgisi: (2024-02-01)

Controlled Study of Atomoxetine in ADHD
Yazar:: J Gordon Millichap
Baskı/Yayın Bilgisi: (2011-06-01)

Atomoxetine-Induced Electrocardiogram Changes
Yazar:: J Gordon Millichap
Baskı/Yayın Bilgisi: (2006-12-01)

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents
Yazar:: S King, ve diğerleri
Baskı/Yayın Bilgisi: (2006-07-01)

A matching-adjusted indirect comparison of centanafadine versus lisdexamfetamine, methylphenidate and atomoxetine in adults with attention-deficit/hyperactivity disorder: long-term safety and efficacy
Yazar:: Jeff Schein, ve diğerleri
Baskı/Yayın Bilgisi: (2024-08-01)

Atomoxetine Open-Label Trial in ADHD
Yazar:: J Gordon Millichap
Baskı/Yayın Bilgisi: (2002-07-01)

Cognitive Test Solution in Mice with Different Brain Weights after Atomoxetine
Yazar:: Olga V. Perepelkina, ve diğerleri
Baskı/Yayın Bilgisi: (2023-05-01)

Neutrophil infiltration regulates clock-gene expression to organize daily hepatic metabolism
Yazar:: María Crespo, ve diğerleri
Baskı/Yayın Bilgisi: (2020-12-01)

MONITORING OF ATOMOXETINE EFFICIENCY IN CORRECTION OF THE SCHOOL DYSADAPTATION
Yazar:: O.A. Sobokar', ve diğerleri
Baskı/Yayın Bilgisi: (2008-09-01)

MONITORING OF ATOMOXETINE EFFICIENCY IN CORRECTION OF THE SCHOOL DYSADAPTATION
Yazar:: O.A. Sobokar', ve diğerleri
Baskı/Yayın Bilgisi: (2008-09-01)

The effect of atomoxetine on random and directed exploration in humans.
Yazar:: Christopher M Warren, ve diğerleri
Baskı/Yayın Bilgisi: (2017-01-01)

Atomoxetine Induced Obsessive-Compulsive Disorder
Yazar:: Mengühan Araz Altay
Baskı/Yayın Bilgisi: (2019-01-01)

Methylphenidate Abuse
Yazar:: J Gordon Millichap
Baskı/Yayın Bilgisi: (1994-11-01)

Methylphenidate and Seizures
Yazar:: J Gordon Millichap
Baskı/Yayın Bilgisi: (1989-10-01)

Melatonin signaling modulates clock genes expression in the mouse retina.
Yazar:: Susumu Hiragaki, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

Off-label use of atomoxetine in adults: is it safe?
Yazar:: Peter Silverstone, ve diğerleri
Baskı/Yayın Bilgisi: (2012-07-01)

A critical appraisal of atomoxetine in the management of ADHD
Yazar:: Childress AC
Baskı/Yayın Bilgisi: (2015-12-01)

Atomoxetine in abstinent cocaine users: Sex differences
Yazar:: Elise E. DeVito, ve diğerleri
Baskı/Yayın Bilgisi: (2017-10-01)

CytochromeP450 2D6 and Atomoxetine Metabolism
Yazar:: J Gordon Millichap
Baskı/Yayın Bilgisi: (2010-10-01)

Role of Sleep Restriction in Daily Rhythms of Expression of Hypothalamic Core Clock Genes in Mice
Yazar:: Weitian Li, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)